source
- Supreme Court questions how far generics makers can go with 'skinny label' drugsWASHINGTON — Supreme Court justices gave a few hints about how they intend to rule in a divisive case for the pharmaceutical industry. In its final argument scheduled for this term, the high court…Endpoints · 3mo ago↗ source
- Merck still sees ‘compelling’ outlook for Terns leukemia drugDespite updated study data that suggest Terns’ treatment may be less differentiated, company executives claimed Thursday that it still could be an important step forward in care.BioPharma Dive · 3mo ago↗ source
- UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapyNews of the submission, which would be the first for UniQure’s closely watched treatment, comes as the therapy faces an uncertain future in the U.S.